News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
82 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37190)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53929)
2023 (42568)
2024 (37443)
2025 (32181)
Month
January (4345)
February (4356)
March (4476)
April (4722)
May (4999)
June (4103)
July (3643)
August (3330)
September (4039)
October (5056)
November (4470)
December (3799)
Day
1 (179)
2 (151)
3 (82)
4 (11)
5 (19)
6 (2)
7 (1)
8 (200)
9 (246)
10 (182)
11 (223)
12 (56)
13 (2)
14 (10)
15 (152)
16 (255)
17 (188)
18 (170)
19 (74)
20 (3)
21 (9)
22 (155)
23 (232)
24 (190)
25 (213)
26 (67)
27 (4)
28 (5)
29 (170)
30 (200)
31 (192)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
Business
Kaycha Group LLC Declares Second-Quarter 2019 Dividend
The board of directors of Kaycha Group LLC today declared a 10-cent dividend, payable August 1, 2019, to members at the close of business on July 1, 2019
July 3, 2019
·
2 min read
Deals
ADDING MULTIMEDIA ZYUS Life Sciences to Acquire Revon Systems
ZYUS Life Sciences Inc. (“ZYUS”) announced today that it has entered into a definitive agreement to acquire the Kentucky-based healthcare technology company Revon Systems, Inc. (“Revon”) in a share for share transaction.
July 3, 2019
·
4 min read
Biotech Beach
ROOT of SKIN™ Skincare Line Sells out in Eighth Consecutive Appearance on QVC Japan
AIVITA Biomedical, Inc., a biotech company specializing in innovative stem cell applications, announced that the Company’s revolutionary stem-cell based ROOT of SKIN™ skincare line sold out in its 8th appearance on the Japanese home shopping channel QVC Japan.
July 3, 2019
·
2 min read
Policy
Pet Supplies Plus Issues Consumer Advisory for Bulk Pig Ear Product
FDA Investigating Contaminated Pig Ear Treats Connecting to Salmonella
July 3, 2019
·
3 min read
Business
Teva to Host Conference Call to Discuss Second Quarter 2019 Financial Results at 8 a.m. ET on August 7, 2019
Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today announced that it will issue a press release on its second quarter 2019 financial results on Wednesday, August 7, 2019 at 7:00 a.m. ET.
July 3, 2019
·
6 min read
Fosun Launches Fourth Edition of Its Acceleration Program “Protechting”
New edition of the program is more international and with an alignment in the themes of sustainable development with social, economic and environmental impact, focusing on three strategic synergies: Healthtech, Insurtech and Fintech.
July 3, 2019
·
6 min read
Policy
Alive Hospice, Notice of Data Privacy Event - July 3, 2019
On or around May 6, 2019, Alive Hospice became aware of unusual activity related to an employee’s email account.
July 3, 2019
·
3 min read
Drug Development
Genentech Announces Positive Results for First Global Phase III Study Investigating One-dose XOFLUZA (Baloxavir Marboxil) in Children With the Flu
The MINISTONE-2 study showed XOFLUZA, given as a new oral suspension, is a well-tolerated and effective potential treatment for the flu in otherwise healthy children aged one to less than 12 years
July 3, 2019
·
7 min read
Business
Health Network Group Takes a Deep Dive into Healthcare in 1776
Health Network Group takes a deep dive into America’s origins in an essay exploring what healthcare, the health insurance industry and medicine looked like in 1776.
July 3, 2019
·
2 min read
Deals
Citryll Completes First Closing of a € 15M Series A to Develop its NETosis Inhibiting Antibody
http://www.citryll.com/ announced the first closing of a targeted € 15 million investment round, funded by ModiQuest B.V., BOM Brabant Ventures, BrightGene, and Curie Capital.
July 3, 2019
·
4 min read
Previous
5 of 9
Next